Literature DB >> 10389933

Biological characterization of subgroups of squamous cell lung carcinomas.

J Mattern1, R Koomägi, M Volm.   

Abstract

Recently, Pezzella et al. (Am. J. Pathol., 1997, 151: 1417-1423, 1997) reported on a subgroup of non-small cell lung carcinomas that had no morphological evidence of neoangiogenesis but appeared to grow and were highly aggressive. In this investigation, we subdivided 87 squamous cell lung carcinomas into four subgroups according to angiogenesis (low and high vessel density) and tumor growth (low and high tumor cell proliferation). The aim was to find differences, if any, in the angiogenic status and clinical behavior between these subgroups. We identified a group of tumors with low angiogenesis and high tumor cell proliferation that was characterized by high expression of vascular endothelial growth factor, low expression of basic fibroblast growth factor, reduced apoptosis, increased incidence of metastases, and short survival times. These data show that even squamous cell lung carcinomas are a heterogeneous group of tumors that can be subdivided in tumors with different biological properties and different clinical behaviors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10389933

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  8 in total

1.  Tumour proliferation, angiogenesis, and ploidy status in human colon cancer.

Authors:  E Cristi; G Perrone; G Toscano; A Verzì; S Nori; D Santini; G Tonini; A Vetrani; A Fabiano; C Rabitti
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

2.  Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.

Authors:  Yuri Shimanuki; Kazuhisa Takahashi; Ri Cui; Satoshi Hori; Fumiyuki Takahashi; Hideaki Miyamoto; Yoshinosuke Fukurchi
Journal:  Lung       Date:  2005 Jan-Feb       Impact factor: 2.584

3.  Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer.

Authors:  R Baillie; J Carlile; N Pendleton; A M Schor
Journal:  J Clin Pathol       Date:  2001-02       Impact factor: 3.411

4.  Anti-oncogenic activity of Chibby in the development of human nasopharyngeal carcinoma.

Authors:  Cheng-Fu Cai; Li-Man Liu; Han-Jing Shangguan; Cun-Shan Liu; Xian-Yang Luo; Yi-Meng Li
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

5.  High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.

Authors:  Jie Hu; Yang Xu; Zao-Zhuo Shen; Zheng Wang; Qing Lu; Guo-Huan Yang; Zheng-Bin Ding; Jia Fan; Jian Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-07       Impact factor: 4.553

6.  Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.

Authors:  Ravi Salgia
Journal:  Cancer Med       Date:  2014-04-08       Impact factor: 4.452

7.  Expression of GLUT3 and HIF-1α in Meningiomas of Various Grades Correlated with Peritumoral Brain Edema.

Authors:  Tao Mei; Zhengjun Wang; Jianwu Wu; Xianhua Liu; Wei Tao; Shousen Wang; Fuyong Chen
Journal:  Biomed Res Int       Date:  2020-08-29       Impact factor: 3.411

8.  GLUT3 expression in cystic change induced by hypoxia in pituitary adenomas.

Authors:  Tao Mei; Jianhe Zhang; Liangfeng Wei; Xingfeng Qi; Yiming Ma; Xianhua Liu; Shaohua Chen; Songyuan Li; Jianwu Wu; Shousen Wang
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.